SCHEMBL8476909

SCHEMBL8476909

CC(C)NC1=NS(=O)(=O)c2sc(Cl)c([N+](=O)[O-])c2N1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.31
CXCR1 P25024 1/20 0.31
CXCR2 P25025 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27506818 0.84
SCHEMBL7073682 0.81 NT5E (0.30)
SCHEMBL8476651 0.80 NT5E (0.30)
SCHEMBL7079890 0.76 NT5E (0.30)
SCHEMBL8719253 0.75 HPGD (0.32)
SCHEMBL7077929 0.70 CXCR2 (0.31) CXCR1CXCR2
SCHEMBL8476764 0.70
SCHEMBL7950990 0.70 NT5E (0.42) CYP2C9CXCR1CXCR2
SCHEMBL8473808 0.69
SCHEMBL2344068 0.68 ABCC8 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1158290-C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use ŵ��Ų�ڿ˹�˾ 2004-07-21 CN disclosed
US-5889002-A CENTRAL NERVOUS SYSTEM DISORDERS; CARDIOVASCULAR DISORDERS; RESPIRATORY SYSTEM DISORDERS; GASTROINTESTINAL DISORDERS; ENDOCRINAL DISEASES NOVO NORDISK A/S (DK) 1999-03-30 US disclosed